These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5226645)

  • 1. The Food and Drug Administration's role in the use of plastic materials.
    Meyers EL
    J Dent Res; 1966; 45(6):1675-82. PubMed ID: 5226645
    [No Abstract]   [Full Text] [Related]  

  • 2. THE FOOD AND DRUG ADMINISTRATION'S ROLE IN THE TESTING OF NEW DRUGS.
    MEYERS EL
    J New Drugs; 1963; 3(6):338-50. PubMed ID: 14113557
    [No Abstract]   [Full Text] [Related]  

  • 3. The food and Drug Administration's view of investigational drugs.
    MEYERS EL
    SD J Med Pharm; 1963 Jul; 16():40-6. PubMed ID: 13935340
    [No Abstract]   [Full Text] [Related]  

  • 4. The food and drug administration's certification of antibiotic drugs for human use.
    Minchew BH
    Dis Chest; 1967 Sep; 52(3):417-9. PubMed ID: 6072046
    [No Abstract]   [Full Text] [Related]  

  • 5. How to comply with the Food and Drug Administration's "Investigational Device Exemption (IDE)" regulations including an application form (revised January 1982).
    Artif Organs; 1982 Feb; 6(1):91-118. PubMed ID: 7073530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Food and Drug Administration's proposed approach to regulation of hematopoietic stem/progenitor cell products for therapeutic use.
    Harvath L
    Transfus Med Rev; 2000 Apr; 14(2):104-11. PubMed ID: 10782496
    [No Abstract]   [Full Text] [Related]  

  • 7. How to comply with the Food and Drug Administration Administration's "Investigational Device Exemption" regulations including an application form (revised January 1982). Prepared by the ISAIO Standards Committee. Part 2.
    Morton WA; Dobelle WH; Lysaght MJ; Serkes K; Siemsen A; Villaroel F
    Artif Organs; 1982 May; 6(2):235-48. PubMed ID: 7125971
    [No Abstract]   [Full Text] [Related]  

  • 8. The Food and Drug Administration's regulation of dental products.
    Pinco RG; Rubin PD
    J Clin Dent; 1995; 6(3):165-9. PubMed ID: 8615957
    [No Abstract]   [Full Text] [Related]  

  • 9. The Food and Drug Administration's requirements for approval of new dental drugs.
    Gilkes CC
    Symp Pharmacol Ther Toxicol Group; 1975 Apr; ():5-12. PubMed ID: 1064180
    [No Abstract]   [Full Text] [Related]  

  • 10. Anchors away: the Food and Drug Administration's use of disgorgement abandons legal moorings.
    Vodra WW; Levine AN
    Food Drug Law J; 2004; 59(1):1-30. PubMed ID: 15190923
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulatory pathways to the market: an overview.
    Morton WA
    Artif Organs; 1982 Nov; 6(4):463-9. PubMed ID: 6762190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Food and Drug Administration's import alerts appear to be "misbranded".
    Humphrey CM
    Food Drug Law J; 2003; 58(4):595-612. PubMed ID: 15027452
    [No Abstract]   [Full Text] [Related]  

  • 13. Protecting protected speech: First Amendment taxonomy and the Food and Drug Administration's regulation of "enduring materials.".
    Gilman DJ
    Food Drug Law J; 2003; 58(3):463-71. PubMed ID: 14626986
    [No Abstract]   [Full Text] [Related]  

  • 14. The Food and Drug Administration's Drug Safety Oversight Board: an evolving paradigm for clinical input on drug safety topics.
    Grandinetti CA; Osborne SF
    Clin Pharmacol Ther; 2010 Aug; 88(2):269-74. PubMed ID: 20531466
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial. Discussion of the Food and Drug Administration's position with respect to certain combinations involving antibiotic drugs.
    J Dist Columbia Dent Soc; 1969 Jul; 44(4):111-2. PubMed ID: 5262515
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of regulatory agencies and industry in assessment of the safety of drugs for use in man. United States Food and Drug Administration's viewpoint.
    Ley HL; Desmond FH
    Can Med Assoc J; 1968 Feb; 98(6):318-21. PubMed ID: 5636100
    [No Abstract]   [Full Text] [Related]  

  • 17. The Food and Drug Administration's early access and fast-track approval initiatives: how have they worked?
    Shulman SR; Brown JS
    Food Drug Law J; 1995; 50(4):503-31. PubMed ID: 10343017
    [No Abstract]   [Full Text] [Related]  

  • 18. The US Food and Drug Administration's New Regulatory Toolkit to Bring Medical Device Innovation Back to the United States.
    Eydelman MB; Nguyen T; Green JA
    JAMA Ophthalmol; 2016 Apr; 134(4):353-4. PubMed ID: 26846511
    [No Abstract]   [Full Text] [Related]  

  • 19. The Food and Drug Administration's over-the-counter drug review: why review OTC drugs?
    Moxley JH; Yingling GL; Edwards CC
    Fed Proc; 1973 Apr; 32(4):1435-7. PubMed ID: 4701750
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of the Food and Drug Administration's current good manufacturing practices regulations to pharmacy practice: a legal view.
    Fink JL
    Contemp Pharm Pract; 1979; 2(4):202-5. PubMed ID: 10244540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.